View email in browser

The MAHA Report logo

President Trump Signs Executive Order Limiting Big Pharma Ads

September 10, 2025

comment
Read on Substack →

By The MAHA Report

At the White House Tuesday evening, Health and Human Services Secretary Robert F. Kennedy Jr. said that President Trump had signed an executive order that will rein in pharmaceutical advertising on television and other media.

According to Kennedy, federal regulations dating back to 1997 will be restored, forcing pharmaceutical companies to clearly disclose all side effects associated with their drugs on all broadcast ads.

Kennedy explained that in 1997 pharmaceutical companies lobbied to remove the ‘full disclosure’ requirement because it lengthened ads, forcing companies to shell out more money.

Video: Sec Kennedy talks about executive order

The post-1997 FDA regulation only required ad companies to disclose some risks; more detailed disclosures could be obtained by telephone.

What’s clear is Big Pharma ads are big business. According to researchers, today pharmaceutical ads make up as much as 75% of ad revenue on cable news shows. Tuesday’s executive order will therefore likely have a major impact on the advertising, pharmaceutical and broadcast industries.

Breaking news: Trump just signed executive order

“Pharmaceutical ads hooked this country on prescription drugs,” the HHS Secretary said, as quoted in a press release posted on the FDA’s website. “We will shut down that pipeline of deception and require drug companies to disclose all critical safety facts in their advertising. Only radical transparency will break the cycle of overmedicalization that drives America’s chronic disease epidemic.”

RFK Jr.

The HHS Secretary also said that direct-to-consumer ads have had a devastating effect on the nation’s health, while the FDA announced that it has begun sending thousands of letters warning pharmaceutical companies to remove “misleading” ads – and issuing cease-and-desist letters to the culpable companies.

“A 2024 review in the Journal of Pharmaceutical Health Services Research reveals that while 100% of pharmaceutical social media posts highlight drug benefits, only 33% mention potential harms,” according to an FDA statement.

MAHA Report logo

Forwarded this email? Subscribe here for more.

Make America Healthy Again™ and MAHA™ are trademarks owned by MAHA TM LLC
Copyright © 2025 MAHA Report. 307 W. 36th St., 11th floor, New York, NY 10018. All rights reserved.

Want to change how you receive these emails?
You can
unsubscribe here.

Our e-mail address is:
[email protected]